TY - JOUR
T1 - Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB
AU - Garding, Angela
AU - Bhattacharya, Nupur
AU - Claus, Rainer
AU - Ruppel, Melanie
AU - Tschuch, Cordula
AU - Filarsky, Katharina
AU - Idler, Irina
AU - Zucknick, Manuela
AU - Caudron-Herger, Maïwen
AU - Oakes, Christopher
AU - Fleig, Verena
AU - Keklikoglou, Ioanna
AU - Allegra, Danilo
AU - Serra, Leticia
AU - Thakurela, Sudhir
AU - Tiwari, Vijay
AU - Weichenhan, Dieter
AU - Benner, Axel
AU - Radlwimmer, Bernhard
AU - Zentgraf, Hanswalter
AU - Wiemann, Stefan
AU - Rippe, Karsten
AU - Plass, Christoph
AU - Döhner, Hartmut
AU - Lichter, Peter
AU - Stilgenbauer, Stephan
AU - Mertens, Daniel
PY - 2013/4
Y1 - 2013/4
N2 - Non-coding RNAs are much more common than previously thought. However, for the vast majority of non-coding RNAs, the cellular function remains enigmatic. The two long non-coding RNA (lncRNA) genes DLEU1 and DLEU2 map to a critical region at chromosomal band 13q14.3 that is recurrently deleted in solid tumors and hematopoietic malignancies like chronic lymphocytic leukemia (CLL). While no point mutations have been found in the protein coding candidate genes at 13q14.3, they are deregulated in malignant cells, suggesting an epigenetic tumor suppressor mechanism. We therefore characterized the epigenetic makeup of 13q14.3 in CLL cells and found histone modifications by chromatin-immunoprecipitation (ChIP) that are associated with activated transcription and significant DNA-demethylation at the transcriptional start sites of DLEU1 and DLEU2 using 5 different semi-quantitative and quantitative methods (aPRIMES, BioCOBRA, MCIp, MassARRAY, and bisulfite sequencing). These epigenetic aberrations were correlated with transcriptional deregulation of the neighboring candidate tumor suppressor genes, suggesting a coregulation in cis of this gene cluster. We found that the 13q14.3 genes in addition to their previously known functions regulate NF-kB activity, which we could show after overexpression, siRNA-mediated knockdown, and dominant-negative mutant genes by using Western blots with previously undescribed antibodies, by a customized ELISA as well as by reporter assays. In addition, we performed an unbiased screen of 810 human miRNAs and identified the miR-15/16 family of genes at 13q14.3 as the strongest inducers of NF-kB activity. In summary, the tumor suppressor mechanism at 13q14.3 is a cluster of genes controlled by two lncRNA genes that are regulated by DNA-methylation and histone modifications and whose members all regulate NF-kB. Therefore, the tumor suppressor mechanism in 13q14.3 underlines the role both of epigenetic aberrations and of lncRNA genes in human tumorigenesis and is an example of colocalization of a functionally related gene cluster.
AB - Non-coding RNAs are much more common than previously thought. However, for the vast majority of non-coding RNAs, the cellular function remains enigmatic. The two long non-coding RNA (lncRNA) genes DLEU1 and DLEU2 map to a critical region at chromosomal band 13q14.3 that is recurrently deleted in solid tumors and hematopoietic malignancies like chronic lymphocytic leukemia (CLL). While no point mutations have been found in the protein coding candidate genes at 13q14.3, they are deregulated in malignant cells, suggesting an epigenetic tumor suppressor mechanism. We therefore characterized the epigenetic makeup of 13q14.3 in CLL cells and found histone modifications by chromatin-immunoprecipitation (ChIP) that are associated with activated transcription and significant DNA-demethylation at the transcriptional start sites of DLEU1 and DLEU2 using 5 different semi-quantitative and quantitative methods (aPRIMES, BioCOBRA, MCIp, MassARRAY, and bisulfite sequencing). These epigenetic aberrations were correlated with transcriptional deregulation of the neighboring candidate tumor suppressor genes, suggesting a coregulation in cis of this gene cluster. We found that the 13q14.3 genes in addition to their previously known functions regulate NF-kB activity, which we could show after overexpression, siRNA-mediated knockdown, and dominant-negative mutant genes by using Western blots with previously undescribed antibodies, by a customized ELISA as well as by reporter assays. In addition, we performed an unbiased screen of 810 human miRNAs and identified the miR-15/16 family of genes at 13q14.3 as the strongest inducers of NF-kB activity. In summary, the tumor suppressor mechanism at 13q14.3 is a cluster of genes controlled by two lncRNA genes that are regulated by DNA-methylation and histone modifications and whose members all regulate NF-kB. Therefore, the tumor suppressor mechanism in 13q14.3 underlines the role both of epigenetic aberrations and of lncRNA genes in human tumorigenesis and is an example of colocalization of a functionally related gene cluster.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Cell Transformation, Neoplastic
KW - Chromatin/genetics
KW - Chromosomes, Human, Pair 13/genetics
KW - DNA Methylation/genetics
KW - Down-Regulation
KW - Epigenesis, Genetic/genetics
KW - Female
KW - HEK293 Cells
KW - Humans
KW - Leukemia/blood
KW - Male
KW - Middle Aged
KW - Mutation
KW - NF-kappa B/metabolism
KW - RNA, Long Noncoding/genetics
KW - Transcription Initiation Site
KW - Transferases
KW - Tumor Suppressor Proteins/blood
KW - Up-Regulation
U2 - 10.1371/journal.pgen.1003373
DO - 10.1371/journal.pgen.1003373
M3 - Journal article
C2 - 23593011
SN - 1553-7390
VL - 9
JO - PLOS Genetics
JF - PLOS Genetics
IS - 4
M1 - e1003373
ER -